Advanced BioDesign as an immunotechnology specialist, provides a tailored and high value solution.
Advanced BioDesign is a French clinical-stage biotechnology company developing an ALDH1 inhibitor to overcome tumour drug resistance. Its goal is to help patients whose cancers resist chemotherapy.
Advanced BioDesign was founded in 2010 by Guillaume Martin, Ismail Ceylan, Mileidys Perez Alea.
Source: Crunchbase.
Traffic estimates from Semrush, latest month.
“Develop ALDH1 inhibitor For overcoming tumour drug resistance mechanisms and transform the landscape of oncology treatment See our Science Company Advanced BioDesign is a clinical stage biotechnology company founded in Advanced Biodesign is driven by the ambition to treat all patients facing chemotherapy-resistant cancers with elevated levels of ALDH1. Since its inception in 2010, this…” a-biodesign.com
Source: company website, checked 2026-10-26.
Search verified work emails and direct dials for people at a-biodesign.com.
Or explore the full B2B database and filter by biopharma companies.